Depo-Testosterone’s Immunomodulatory Role in Allergy Management for American Males
Reading Time: 3 minutesIntroduction Allergic diseases, including seasonal rhinitis, asthma, and atopic dermatitis, affect over 50 million Americans annually, with men comprising a significant subset despite lower prevalence compared to women. In the United States, where environmental allergens like pollen and urban pollutants exacerbate symptoms, novel therapeutic strategies are urgently needed. Pfizer's Depo-Testosterone (testosterone cypionate), a long-acting intramuscular androgen formulation primarily indicated for... Read more »
